All SEC Filings :: Ligand Pharmaceuticals Incorporated (LGND)

Filter Filings:

Date	Form	Description	Docs	XBRL	Pages
05/14/99	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-3.3 EX-10.3 EX-10.4 EX-27.1			69
04/16/99	DEF 14A	Definitive proxy statements			60
03/31/99	10-K	Annual report pursuant to Section 13 and 15(d) Related Documents EX-10.194 EX-10.195 EX-10.196 EX-21.1 EX-23.1 EX-27.1			156
02/09/99	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions			6
01/06/99	SC 13D	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Related Documents EX-1 EX-2			69
12/30/98	S-8	Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Related Documents EX-5.1 EX-23.2 EX-99.1 EX-99.2			52
12/24/98	8-A12G/A	Form for registration of a class of securities pursuant to Section 12(g) Related Documents EX-1			4
11/25/98	10-K/A	Annual report pursuant to Section 13 and 15(d) Related Documents EX-10.169 EX-10.172			42
11/16/98	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-10.1 EX-10.2 EX-10.3 EX-10.4 EX-10.5 EX-10.6 EX-10.7 EX-27.1			67
11/10/98	8-A12G/A	Form for registration of a class of securities pursuant to Section 12(g) Related Documents EX-99.1			6